SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-003920
Filing Date
2018-01-17
Accepted
2018-01-17 16:05:46
Documents
1
Period of Report
2018-01-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4081
  Complete submission text file 0001209191-18-003920.txt   5445
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. 113 CEDAR STREET, STE S-7 MILFORD MA 01757
Business Address
Freve Jonathan (Reporting) CIK: 0001664466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 18531550